ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 276

Development of a Longitudinal, Propective Cohort of Young Adults with Childhood-Onset Systemic Lupus Erythematosus

Aimee Hersh1, Erica F. Lawson2, Emily von Scheven3, Edward H. Yelin4 and John F. Bohnsack5, 1Pediatrics, University of Utah, Salt Lake City, UT, 2Pediatric Rheumatology, UC San Francisco, San Francisco, CA, 3Pediatric Rheumatology, University of California, San Francisco, San Francisco, CA, 4Medicine, UC San Francisco, San Francisco, CA, 5Dept of Pediatriacs, University of Utah, Salt Lake City, UT

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Pediatric rheumatology and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Data on the adult outcomes of childhood-onset systemic lupus erythematosus (cSLE ) are lacking, and a feasible methodology is needed to obtain long-term follow-up on these patients after transition from pediatric to adult rheumatology care. The purpose of this study was to use established methodology to develop a prospective longitudinal cohort study of young adults with cSLE, in order to assess long-term clinical, socioeconomic and behavioral health outcomes.

Methods: Based on prior methodology utilized in the University of California San Francisco Lupus Outcomes Study (Yelin, 2007), a 45 minute baseline in-depth telephone interview survey was developed which includes patient-reported validated items pertaining to multiple domains including demographic and socioeconomic characteristics, cumulative disease manifestations, recent SLE activity and assessment of the transition from pediatric to adult rheumatology care. The survey was pilot tested and revised based on responses from the pilot testing. The initial cohort was developed by querying the clinical database from the University of Utah pediatric rheumatology clinic to identify patients diagnosed with cSLE (age <18 years at diagnosis) who are currently 18-30 years of age and met ACR criteria for SLE at diagnosis.  Potential subjects were contacted by mail using their last known address in their medical record; interested subjects who received mailings returned a response card indicating their interest in study participation. These subjects were contacted by phone and completed the baseline interviews, and will be interviewed annually.

Results: 109 potential subjects were identified and contacted by mail, 50 subjects indicated an interest in participating; no response forms were returned which declined participation in the study.  Twenty-six potential subjects were not reachable due to out of date contact information and 8 subjects were deceased. To date, 41 subjects have completed the baseline interview. Median age is 24 years (range 18-30), median disease duration is 11 years (range 4-20). The cohort is 95% female, ethnicities include Caucasian (78%), Hispanic (15%) and other (7%). Sixty-eight percent of subjects reported a history of renal disease; 51% had a history of renal biopsy and 2 subjects had a renal transplant. Nine subjects (22%) reported a lupus flare in the 3 months prior to the baseline interview. Eleven (26%) of subjects reported an emergency room visit for their SLE within the past year, nine (22%) subjects were hospitalized. Eight-five percent of subjects rated their health as “excellent/very good/good” and 15% rated their health as “fair/poor.” Thirteen (32%) of subjects reported a lapse in insurance since turning 18, seven (17%) of subjects reported that this had a direct, negative impact on their health.

Conclusion: This abstract describes the successful establishment of a prospective longitudinal cohort of patients with cSLE as they enter adulthood. Such an inception cohort will permit the accurate estimation of the impact of biologic, socioeconomic, behavioral and access-to-care factors on disease outcomes over time.


Disclosure:

A. Hersh,
None;

E. F. Lawson,
None;

E. von Scheven,
None;

E. H. Yelin,
None;

J. F. Bohnsack,

Novartis Pharmaceutical Corporation,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-longitudinal-propective-cohort-of-young-adults-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology